906559-46-4

Basic information

• Product Name: Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate
• Synonyms: Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate;4-[2-Chloro-4-(methoxycarbonyl)phenyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester
• CAS NO: 906559-46-4
• Molecular Formula: C₁₇H₂₃ClN₂O₄
• Molecular Weight: 355
• Mol File: 906559-46-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate(906559-46-4)
• EPA Substance Registry System: Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate(906559-46-4)

Safety Data

• Hazardous Substances Data: 906559-46-4(Hazardous Substances Data)

Usage

General Description

Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate is a chemical compound with the molecular formula C16H22ClN3O4. It is a derivative of piperazine, a heterocyclic organic compound, and is commonly used in the synthesis of pharmaceutical drugs and other organic compounds. The compound is a chlorinated ester with a methyl group and a Boc-protected piperazine moiety, making it suitable for use in the production of various pharmaceuticals and agrochemicals. Methyl 4-(4-Boc-1-piperazinyl)-3-chlorobenzoate has potential applications in medicinal chemistry and drug development due to its ability to modify biological activity and pharmacokinetic properties.

Upstream product

• 403-16-7 3-chloro-4-fluorobenzoic acid 
• 234082-35-0 methyl 3-chloro-4-fluorobenzoate 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 

Downstream Products

• 1236119-57-5 3-chloro-N-methyl-4-(piperazin-1-yl)benzamide 

Relevant articles and documents

POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS

The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula: The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.

PYRIDYL AND PHENYL SUBSTITUTED PIPERAZINE-PIPERIDINES WITH CXCR3 ANTAGONIST ACTIVITY

The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts, solvates or esters of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: and the pharmaceutically acceptable salts, solvates and esters thereof. Also disclosed is a method of treating chemokine mediated diseases, such as, palliative therapy, curative therapy, prophylactic therapy of certain diseases and conditions such as inflammatory diseases (non limiting example(s) include, psoriasis), autoimmune diseases (non limiting example(s) include, rheumatoid arthritis, multiple sclerosis), graft rejection (non limiting example(s) include, allograft rejection, xenograft rejection), infectious diseases (e.g , tuberculoid leprosy), fixed drug eruptions, cutaneous delayed-type hypersensitivity responses, ophthalmic inflammation, type I diabetes, viral meningitis and tumors using a compound of Formula 1.